Table 1.

Descriptive analysis of the two groups.

	Group 1 (Pre-Adrenal MTE)	Group 2 (Post-Adrenal MTE)	p
gender (% females)	28%	63%	0.053
age at diagnosis (mean)	56.29	50.24	0.230
incidental finding yes/no	2/14	11/20	0.178
secretion yes/no	9/14	18/33	0.093
EDP yes/no	7/14	17/33	1.000
second-line treatments yes/no	7/14	14/33	0.752
RT yes/no	2/14	7/33	0.704
primary surgery yes/no	10/14	29/33	0.215
secondary surgery for metastasis yes/no	4/14	8/33	0.731
stage I-II	4/14	8/33	0.745
stage III	1/14	5/33
stage IV	9/14	20/33
total n° of second-line treatments (mean)	1.71	2.5	0.292